- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.88 Form of Notice of Grant of Stock Options
- 10.89 Stock Ownership Policy
- 21 Subsidiaries of Registrant
- 23.1 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
- 23.2 Consent of Haskell White LLP, Independent Registered Public Accouting Firm
- 31.1 Certification of Chief Executive Officer - Section 302
- 31.2 Certification of Chief Financial Officer - Section 302
- 32 Certification Pursuant to 18 U.s.c. Section 1350 - Section 906
EXHIBIT 23.1
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-108948, 333-112043 and 333-122026) of Cortex Pharmaceuticals, Inc. and in the related Prospectus and in the Registration Statements (Form S-8 Nos. 333-102042, 333-82477 and 333-20777) pertaining to the 1996 Stock Incentive Plan, the 1989 Incentive Stock Option, Nonqualified Stock Option and Stock Purchase Plan, the 1989 Special Nonqualified Stock Option and Stock Purchase Plan and the Executive Stock Plan, of Cortex Pharmaceuticals, Inc. of our report dated July 27, 2004, with respect to the financial statements of Cortex Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2004.
/s/ Ernst & Young LLP
San Diego, California
March 17, 2005